Cargando…
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis
The role of apoptosis in melanoma pathogenesis and chemoresistance is poorly characterized. Mutations in TP53 occur infrequently, yet the TP53 apoptotic pathway is often abrogated. This may result from alterations in TP53 family members, including the TP53 homologue TP63. Here we demonstrate that TP...
Autores principales: | Matin, Rubeta N., Chikh, Anissa, Law Pak Chong, Stephanie, Mesher, David, Graf, Manuela, Sanza’, Paolo, Senatore, Valentina, Scatolini, Maria, Moretti, Francesca, Leigh, Irene M., Proby, Charlotte M., Costanzo, Antonio, Chiorino, Giovanna, Cerio, Rino, Harwood, Catherine A., Bergamaschi, Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600906/ https://www.ncbi.nlm.nih.gov/pubmed/23420876 http://dx.doi.org/10.1084/jem.20121439 |
Ejemplares similares
-
p63 is a key regulator of iRHOM2 signalling in the keratinocyte stress response
por: Arcidiacono, Paola, et al.
Publicado: (2018) -
p63 inhibits CD44(+)/CD24(−) cell proliferation and chemoresistance in papillary thyroid carcinoma cells
por: Guo, Jing-Jing, et al.
Publicado: (2017) -
The C repressor of the P2 bacteriophage
por: Massad, Tariq, et al.
Publicado: (2015) -
Treasure or Artifact: A Decade of p63 Research Speaks for Itself
por: Mikkola, Marja L., et al.
Publicado: (2010) -
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression
por: Chikh, Anissa, et al.
Publicado: (2016)